Hi MassBio Community!
Lonza Biologics’ East Coast BD team is hosting an Early Development Roadshow in Boston from February 10th-12th. If your company is working on developing a protein or peptide biotherapeutic and would like to learn insights on how to accelerate your path to the clinic, we invite you to meet with us and discuss more.
Suggested topics to address with our expert and Head of the Early Development Services, Yvette Stallwood, could include:
• In Vitro Immunogenicity Risk Assessment where primary cell-based assays assess the risk of unwanted (or wanted) immunogenicity; an essential component of your regulatory submission.
• Epibase T Cell Epitope Screening Platform for comprehensive assessment.
• Expertise in Mammalian Expression platforms
Please contact Amanda Holmsten, BD Specialist, directly via amanda.holmsten@lonza.com to book a meeting. More information can be found on the link below. We look forward to welcoming you to the roadshow and supporting your development journey!
https://cdmo.lonza.com/us-east-mm-feb2025-amanda/p/1